{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:10:50Z","timestamp":1790935850576,"version":"4.1.0"},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamadermatol.2021.1273","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T11:14:12Z","timestamp":1620818052000},"page":"691","source":"Crossref","is-referenced-by-count":101,"title":["Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders"],"prefix":"10.1001","volume":"157","author":[{"given":"Jonathan I.","family":"Silverberg","sequence":"first","affiliation":[{"name":"Department of Dermatology, George Washington University School of Medicine, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Simpson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wollenberg","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergy, Ludwig Maximillian University, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bissonnette","sequence":"additional","affiliation":[{"name":"Innovaderm Research, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kyoto University, Graduate School of Medicine, Kyoto, Japan"},{"name":"Skin Research Institute of Singapore and Singapore Immunology Network, A*Star, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"DeLozier","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Sun","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Cardillo","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio P.","family":"Nunes","sequence":"additional","affiliation":[{"name":"now with Janssen, Titusville, New Jersey"},{"name":"at the time of the trial, Eli Lilly and Company, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Reich","sequence":"additional","affiliation":[{"name":"Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"10247","key":"doi210018r1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(20)31286-1","article-title":"Atopic dermatitis.","volume":"396","author":"Langan","year":"2020","journal-title":"Lancet"},{"key":"doi210018r2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/CCID","article-title":"Treatment-resistant atopic dermatitis: challenges and solutions.","volume":"12","author":"Johnson","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"12","key":"doi210018r3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/jdv.v34.12","article-title":"ETFAD\/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.","volume":"34","author":"Wollenberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"doi210018r4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3\u2014management and treatment with phototherapy and systemic agents.","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"doi210018r5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.anai.2019.10.005","article-title":"New treatments for atopic dermatitis targeting beyond IL-4\/IL-13 cytokines.","volume":"124","author":"Renert-Yuval","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"doi210018r6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/jdv.2018.32.issue-6","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"doi210018r7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40257-018-0370-9","article-title":"Dupilumab: a review in moderate-to-severe atopic dermatitis.","volume":"19","author":"Frampton","year":"2018","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"doi210018r8","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaad.2020.08.051","article-title":"Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis.","volume":"84","author":"Halling","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"doi210018r9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/bjd.v183.2","article-title":"Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials.","volume":"183","author":"Simpson","year":"2020","journal-title":"Br J Dermatol"},{"issue":"12","key":"doi210018r10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamadermatol.2020.3260","article-title":"Efficacy and safety of baricitinib combined with topical corticosteroids for treatment of moderate to severe atopic dermatitis: a randomized clinical trial.","volume":"156","author":"Reich","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"20","key":"doi210018r11","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"10086","key":"doi210018r12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"issue":"2","key":"doi210018r13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/jdv.v35.2","article-title":"Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials.","volume":"35","author":"Bieber","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2779639\/jamadermatology_silverberg_2021_oi_210018_1623774318.15957.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T11:01:37Z","timestamp":1623841297000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2779639"}},"subtitle":["An Extension Study of 2 Randomized Clinical Trials"],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2021.1273","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}